statistiche ricercatore

Continente	#
EU - Europa	1.979
NA - Nord America	1.554
AS - Asia	754
SA - Sud America	121
Continente sconosciuto - Info sul continente non disponibili	28
AF - Africa	18
OC - Oceania	7
Totale	4.461

Nazione	#
US - Stati Uniti d'America	1.520
DE - Germania	1.217
SG - Singapore	294
CN - Cina	244
SE - Svezia	146
IT - Italia	126
GB - Regno Unito	112
BR - Brasile	97
UA - Ucraina	97
FR - Francia	96
VN - Vietnam	51
PL - Polonia	46
IN - India	36
IE - Irlanda	32
RU - Federazione Russa	29
FI - Finlandia	24
TR - Turchia	19
ID - Indonesia	17
CA - Canada	14
HK - Hong Kong	14
JP - Giappone	13
BE - Belgio	11
ES - Italia	11
BD - Bangladesh	9
AR - Argentina	8
NL - Olanda	8
IR - Iran	7
MX - Messico	7
PH - Filippine	7
ZA - Sudafrica	7
AU - Australia	6
PK - Pakistan	6
RO - Romania	6
EC - Ecuador	5
IQ - Iraq	5
KR - Corea	5
CO - Colombia	4
EG - Egitto	4
UZ - Uzbekistan	4
AE - Emirati Arabi Uniti	3
DZ - Algeria	3
JM - Giamaica	3
MY - Malesia	3
SA - Arabia Saudita	3
TT - Trinidad e Tobago	3
VE - Venezuela	3
AO - Angola	2
AT - Austria	2
AZ - Azerbaigian	2
BS - Bahamas	2
CH - Svizzera	2
CZ - Repubblica Ceca	2
IL - Israele	2
LT - Lituania	2
OM - Oman	2
PT - Portogallo	2
PY - Paraguay	2
A1 - Anonimo	1
AL - Albania	1
AM - Armenia	1
CI - Costa d'Avorio	1
CL - Cile	1
CR - Costa Rica	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
EU - Europa	1
GE - Georgia	1
GP - Guadalupe	1
HN - Honduras	1
HR - Croazia	1
HU - Ungheria	1
JO - Giordania	1
KZ - Kazakistan	1
LB - Libano	1
LK - Sri Lanka	1
LU - Lussemburgo	1
LV - Lettonia	1
NO - Norvegia	1
NP - Nepal	1
NZ - Nuova Zelanda	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TN - Tunisia	1
UY - Uruguay	1
VC - Saint Vincent e Grenadine	1
Totale	4.435

Nome	#
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth	519
Small intestinal bacterial overgrowth recurrence after antibiotic therapy	512
The Role of Methane in Intestinal Diseases.	476
Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?	378
Bacillus clausii as a treatment of small intestinal bacterial overgrowth.	316
ag)Association between hypothyroidism and small intestinal bacterial overgrowth	289
The role of small intestinal bacterial overgrowth in Parkinson's disease	265
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.	251
-High prevalence of celiac disease in patients with lactose intolerance	238
Small intestinal bacterial overgrowth and intestinal permeability.	214
Rifaximin pharmacology and clinical implications.	185
Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet.	176
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth	175
Gut microbiota and obesity.	170
ag) Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.	169
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.	128
Totale	4.461

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	180	0	0	0	11	24	8	3	40	8	8	27	51
2022/2023	400	54	57	38	75	17	46	25	32	45	3	5	3
2023/2024	166	7	51	2	2	3	27	2	19	1	9	30	13
2024/2025	297	7	11	27	4	34	14	1	23	39	22	57	58
2025/2026	794	134	26	34	72	155	46	175	37	39	40	24	12
2026/2027	459	52	211	144	52	0	0	0	0	0	0	0	0
Totale													4.461

IRIS UniCatt